Saliva as a diagnostic sample of SARS-CoV-2: an integrative review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Revista Uningá (Online) |
DOI: | 10.46311/2318-0579.59.eUJ4358 |
Texto Completo: | https://revista.uninga.br/uninga/article/view/4358 |
Resumo: | In March 2020, the disease caused by the new coronavirus (SARS-CoV-2) was characterized as a pandemic. Due to the magnitude that the disease has reached and its unprecedented character, a growing scientific interest in the disease has emerged, with searches to find new diagnostic methods, increasing the speed to obtain test results and, consequently, a better epidemiological mapping of the disease. This integrative review aims to analyze the main scientific evidence on the use of saliva as a diagnostic method for COVID-19. In the present integrative review, searches were conducted in four electronic databases in March 2022, namely: PubMed, in which results were included exclusively in English, and in the platforms Google Scholar, SciELO and Virtual Health Library (VHL), with the inclusion of results strictly in Portuguese. Different keywords were used according to the dominant language of the databases, being in PubMed in English language chosen ''SARS-CoV-2'', ''saliva'', ''diagnosis'', ''viral load'' and ''coronavirus COVID-19'' and in the other platforms, in Portuguese language ''saliva'', ''covid'' and ''diagnosis''. Among the 45 articles included and analyzed, more than half classified saliva as an alternative or complementary diagnostic method. Yet, only three articles out of the total number classified saliva as an unviable sample for diagnostic testing. Thus, saliva showed positive results as a diagnostic option and for COVID-19 follow-up and monitoring. However, despite the limitations of the studies, the saliva sample in pediatric patients suggests having low sensitivity. |
id |
UNINGA-1_ad725164abd9cea0bd8ed14883d2e47f |
---|---|
oai_identifier_str |
oai:ojs.revista.uninga.br:article/4358 |
network_acronym_str |
UNINGA-1 |
network_name_str |
Revista Uningá (Online) |
spelling |
Saliva as a diagnostic sample of SARS-CoV-2: an integrative reviewSaliva como método diagnóstico do SARS-CoV-2: uma revisão integrativaCovid-19salivaSARS-CoV-2testes para Covid-19COVID-19COVID-19 testssalivaSARS-CoV-2In March 2020, the disease caused by the new coronavirus (SARS-CoV-2) was characterized as a pandemic. Due to the magnitude that the disease has reached and its unprecedented character, a growing scientific interest in the disease has emerged, with searches to find new diagnostic methods, increasing the speed to obtain test results and, consequently, a better epidemiological mapping of the disease. This integrative review aims to analyze the main scientific evidence on the use of saliva as a diagnostic method for COVID-19. In the present integrative review, searches were conducted in four electronic databases in March 2022, namely: PubMed, in which results were included exclusively in English, and in the platforms Google Scholar, SciELO and Virtual Health Library (VHL), with the inclusion of results strictly in Portuguese. Different keywords were used according to the dominant language of the databases, being in PubMed in English language chosen ''SARS-CoV-2'', ''saliva'', ''diagnosis'', ''viral load'' and ''coronavirus COVID-19'' and in the other platforms, in Portuguese language ''saliva'', ''covid'' and ''diagnosis''. Among the 45 articles included and analyzed, more than half classified saliva as an alternative or complementary diagnostic method. Yet, only three articles out of the total number classified saliva as an unviable sample for diagnostic testing. Thus, saliva showed positive results as a diagnostic option and for COVID-19 follow-up and monitoring. However, despite the limitations of the studies, the saliva sample in pediatric patients suggests having low sensitivity.Em março de 2020, a doença causada pelo novo coronavírus (SARS-CoV-2) foi caracterizada como uma pandemia. Em decorrência da magnitude que a doença alcançou e seu caráter inédito, um crescente interesse científico sobre a mesma surgiu, com buscas para se encontrarem novos métodos diagnósticos, aumentando a velocidade para a obtenção dos resultados dos testes e, consequentemente, um melhor mapeamento epidemiológico da doença. Esta revisão integrativa tem como objetivo analisar as principais evidências científicas sobre a utilização da saliva como método diagnóstico da Covid-19. Na presente revisão integrativa, foram realizadas buscas em quatro bases de dados eletrônicas, em março de 2022, sendo elas: PubMed, em que foram inclusos resultados exclusivamente em inglês, e nas plataformas Google acadêmico, SciELO e Biblioteca Virtual de Saúde (BVS), havendo a inclusão dos resultados restritamente em português. Foram utilizadas diferentes palavras-chave de acordo com a linguagem dominante das bases de dados, sendo no PubMed em língua inglesa escolhidos ‘’SARS-CoV-2´´, ‘’saliva’’, ‘’diagnosis’’, ‘’viral load’’ e ‘’coronavirus Covid-19’’ e nas demais plataformas, em língua portuguesa ‘’saliva’’, ‘’covid’’ e ‘’diagnósticos’’. Dentre os 45 artigos incluídos e analisados, mais da metade classificaram a saliva como um método diagnóstico alternativo ou complementar. Ainda, apenas três artigos do número total classificaram a saliva como uma amostra inviável para os testes de diagnóstico. Dessa forma, a saliva mostrou resultados positivos como uma opção de diagnóstico e para o acompanhamento e monitoramento da Covid-19. No entanto, apesar das limitações dos estudos, a amostra salivar em pacientes pediátricos sugere ter baixa sensibilidade.Editora Uningá2022-12-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTextoinfo:eu-repo/semantics/otherapplication/pdfapplication/pdfhttps://revista.uninga.br/uninga/article/view/435810.46311/2318-0579.59.eUJ4358Revista Uningá; Vol. 59 (2022); eUJ4358Revista Uningá; v. 59 (2022); eUJ43582318-057910.46311/ru.v59ireponame:Revista Uningá (Online)instname:Centro Universitário Uningáinstacron:UNINGAporenghttps://revista.uninga.br/uninga/article/view/4358/2536https://revista.uninga.br/uninga/article/view/4358/2537Copyright (c) 2022 Revista Uningáhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessNogueira, Bruna de Paula Orcina, Bernardo da Fonseca Oliveira, Rodrigo Cardoso deSantos, Paulo Sérgio da Silva 2024-01-15T17:24:48Zoai:ojs.revista.uninga.br:article/4358Revistahttps://revista.uninga.br/uninga/indexPUBhttps://revista.uninga.br/uninga/oairevistauninga@uninga.edu.br2318-05792318-0579opendoar:2024-01-15T17:24:48Revista Uningá (Online) - Centro Universitário Uningáfalse |
dc.title.none.fl_str_mv |
Saliva as a diagnostic sample of SARS-CoV-2: an integrative review Saliva como método diagnóstico do SARS-CoV-2: uma revisão integrativa |
title |
Saliva as a diagnostic sample of SARS-CoV-2: an integrative review |
spellingShingle |
Saliva as a diagnostic sample of SARS-CoV-2: an integrative review Saliva as a diagnostic sample of SARS-CoV-2: an integrative review Nogueira, Bruna de Paula Covid-19 saliva SARS-CoV-2 testes para Covid-19 COVID-19 COVID-19 tests saliva SARS-CoV-2 Nogueira, Bruna de Paula Covid-19 saliva SARS-CoV-2 testes para Covid-19 COVID-19 COVID-19 tests saliva SARS-CoV-2 |
title_short |
Saliva as a diagnostic sample of SARS-CoV-2: an integrative review |
title_full |
Saliva as a diagnostic sample of SARS-CoV-2: an integrative review |
title_fullStr |
Saliva as a diagnostic sample of SARS-CoV-2: an integrative review Saliva as a diagnostic sample of SARS-CoV-2: an integrative review |
title_full_unstemmed |
Saliva as a diagnostic sample of SARS-CoV-2: an integrative review Saliva as a diagnostic sample of SARS-CoV-2: an integrative review |
title_sort |
Saliva as a diagnostic sample of SARS-CoV-2: an integrative review |
author |
Nogueira, Bruna de Paula |
author_facet |
Nogueira, Bruna de Paula Nogueira, Bruna de Paula Orcina, Bernardo da Fonseca Oliveira, Rodrigo Cardoso de Santos, Paulo Sérgio da Silva Orcina, Bernardo da Fonseca Oliveira, Rodrigo Cardoso de Santos, Paulo Sérgio da Silva |
author_role |
author |
author2 |
Orcina, Bernardo da Fonseca Oliveira, Rodrigo Cardoso de Santos, Paulo Sérgio da Silva |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Nogueira, Bruna de Paula Orcina, Bernardo da Fonseca Oliveira, Rodrigo Cardoso de Santos, Paulo Sérgio da Silva |
dc.subject.por.fl_str_mv |
Covid-19 saliva SARS-CoV-2 testes para Covid-19 COVID-19 COVID-19 tests saliva SARS-CoV-2 |
topic |
Covid-19 saliva SARS-CoV-2 testes para Covid-19 COVID-19 COVID-19 tests saliva SARS-CoV-2 |
description |
In March 2020, the disease caused by the new coronavirus (SARS-CoV-2) was characterized as a pandemic. Due to the magnitude that the disease has reached and its unprecedented character, a growing scientific interest in the disease has emerged, with searches to find new diagnostic methods, increasing the speed to obtain test results and, consequently, a better epidemiological mapping of the disease. This integrative review aims to analyze the main scientific evidence on the use of saliva as a diagnostic method for COVID-19. In the present integrative review, searches were conducted in four electronic databases in March 2022, namely: PubMed, in which results were included exclusively in English, and in the platforms Google Scholar, SciELO and Virtual Health Library (VHL), with the inclusion of results strictly in Portuguese. Different keywords were used according to the dominant language of the databases, being in PubMed in English language chosen ''SARS-CoV-2'', ''saliva'', ''diagnosis'', ''viral load'' and ''coronavirus COVID-19'' and in the other platforms, in Portuguese language ''saliva'', ''covid'' and ''diagnosis''. Among the 45 articles included and analyzed, more than half classified saliva as an alternative or complementary diagnostic method. Yet, only three articles out of the total number classified saliva as an unviable sample for diagnostic testing. Thus, saliva showed positive results as a diagnostic option and for COVID-19 follow-up and monitoring. However, despite the limitations of the studies, the saliva sample in pediatric patients suggests having low sensitivity. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-12-03 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Texto info:eu-repo/semantics/other |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://revista.uninga.br/uninga/article/view/4358 10.46311/2318-0579.59.eUJ4358 |
url |
https://revista.uninga.br/uninga/article/view/4358 |
identifier_str_mv |
10.46311/2318-0579.59.eUJ4358 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://revista.uninga.br/uninga/article/view/4358/2536 https://revista.uninga.br/uninga/article/view/4358/2537 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2022 Revista Uningá https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2022 Revista Uningá https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Editora Uningá |
publisher.none.fl_str_mv |
Editora Uningá |
dc.source.none.fl_str_mv |
Revista Uningá; Vol. 59 (2022); eUJ4358 Revista Uningá; v. 59 (2022); eUJ4358 2318-0579 10.46311/ru.v59i reponame:Revista Uningá (Online) instname:Centro Universitário Uningá instacron:UNINGA |
instname_str |
Centro Universitário Uningá |
instacron_str |
UNINGA |
institution |
UNINGA |
reponame_str |
Revista Uningá (Online) |
collection |
Revista Uningá (Online) |
repository.name.fl_str_mv |
Revista Uningá (Online) - Centro Universitário Uningá |
repository.mail.fl_str_mv |
revistauninga@uninga.edu.br |
_version_ |
1822182051400384512 |
dc.identifier.doi.none.fl_str_mv |
10.46311/2318-0579.59.eUJ4358 |